BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lu MY, Yeh ML, Huang CI, Wang SC, Tsai YS, Tsai PC, Ko YM, Lin CC, Chen KY, Wei YJ, Hsu PY, Hsu CT, Jang TY, Liu TW, Liang PC, Hsieh MY, Lin ZY, Chen SC, Huang CF, Huang JF, Dai CY, Chuang WL, Yu ML. Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication. World J Gastroenterol 2022; 28(1): 140-153 [PMID: 35125824 DOI: 10.3748/wjg.v28.i1.140]
URL: https://www.wjgnet.com/1007-9327/full/v28/i1/140.htm
Number Citing Articles
1
Jin Lei, Sibo Yang, Bowen Chen, Linzhi Zhang, Tao Yan, Gangqi Yang, Yue Chen, Yinyin Li, Yinying Lu, Shi Zuo. Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2023; : 357 doi: 10.2147/JHC.S392347
2
Paula Fernández-Alvarez, María Fernanda Guerra-Veloz, Angel Vilches-Arenas, Patricia Cordero-Ruíz, Francisco Bellido-Muñoz, Angel Caunedo-Alvarez, Isabel Carmona-Soria. Dynamic Changes in Non-Invasive Markers of Liver Fibrosis Are Predictors of Liver Events after SVR in HCV PatientsViruses 2023; 15(6): 1251 doi: 10.3390/v15061251
3
Ashraf Elbahrawy, Hassan Atalla, Abdulla A. Mahmoud, Ahmed Eliwa, Alaa Alsawak, Mohamed Alboraie, Ali Madian, Ahmed Alashker, Sadek Mostafa, Ahmed Alwassief, Hussein H. Aly. Prediction and surveillance of de novo HCC in patients with compensated advanced chronic liver disease after hepatitis C virus eradication with direct antiviral agentsFrontiers in Virology 2023; 3 doi: 10.3389/fviro.2023.1227317
4
Patrícia Rocha Martins, Kátia Luciano Pereira Morais, Nayane Alves de Lima Galdino, Adriana Jacauna, Sálua O. C. Paula, Wagner C. S. Magalhães, Luciana W. Zuccherato, Larissa S. Campos, Paulo Guilherme O. Salles, Kenneth J. Gollob. Linking tumor immune infiltrate and systemic immune mediators to treatment response and prognosis in advanced cervical cancerScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-49441-2
5
Hamidreza Karimi-Sari, Damani A Piggott, Eileen P Scully, Kathleen Ward, Catherine G Sutcliffe, Mark Sulkowski, Oluwaseun Falade-Nwulia. Changes in Inflammatory Cytokines After Chronic Hepatitis C Treatment Among People Living With HIVOpen Forum Infectious Diseases 2024; 11(1) doi: 10.1093/ofid/ofad623
6
Iman Ibrahim Salama, Hala M Raslan, Ghada A Abdel-Latif, Somaia I Salama, Samia M Sami, Fatma A Shaaban, Aida M Abdelmohsen, Walaa A Fouad. Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infectionWorld Journal of Hepatology 2022; 14(6): 1053-1073 doi: 10.4254/wjh.v14.i6.1053